InvestorsHub Logo

Rhew123

03/15/17 10:29 AM

#258 RE: biotech_researcher #257

I believe that they said a good chunk of it was Entyce due to the delay... but that that inventory would still be usable once it can start shipping... as well as Galliprant inventory value adjustment due to market value terms agreed upon with Elanco.

I think they have a bit of a runway on cash... on average spending $14 mil per quarter "operating burn" - that will be a bit higher due to full sales team however - but with $88 million in cash, that's a bit of room...

4th quarter '17 will need to be solid for sure!